Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.34% | 3.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.34% | 3.17% | |||
| Cost of Revenue | 4.03% | 2.73% | |||
| Gross Profit | -1.50% | 3.40% | |||
| SG&A Expenses | 1.08% | 1.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -14.77% | -8.01% | |||
| Total Operating Expenses | 2.31% | 2.43% | |||
| Operating Income | -5.21% | 5.32% | |||
| Income Before Tax | -24.61% | 249.70% | |||
| Income Tax Expenses | -41.88% | 249.97% | |||
| Earnings from Continuing Operations | -19.74% | 249.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.74% | 249.62% | |||
| EBIT | -5.21% | 5.32% | |||
| EBITDA | -4.17% | 5.01% | |||
| EPS Basic | -19.81% | 249.61% | |||
| Normalized Basic EPS | -18.50% | 5.57% | |||
| EPS Diluted | -19.78% | 249.56% | |||
| Normalized Diluted EPS | -18.50% | 5.57% | |||
| Average Basic Shares Outstanding | 0.09% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.00% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -- | -- | |||